Hyphens Pharma International Limited logo

Hyphens Pharma International Limited (1J5)

Market Open
14 Aug, 03:24
SGX SGX
S$
0. 37
-0
-1.3513%
S$
108.11M Market Cap
- P/E Ratio
- Div Yield
867,000 Volume
- Eps
S$ 0.37
Previous Close
Add Transaction
Day Range
0.37 0.37
Year Range
0.29 0.4
Want to track 1J5 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

1J5 trading today lower at S$0.37, a decrease of -1.3513% from yesterday's close, completing a monthly increase of 4.2857% or S$0.02. Over the past 12 months, 1J5 stock gained 8.9552%.
1J5 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

1J5 Chart

People also search for

40T
Isec Healthcare Ltd.
S$ 0.32
0%
5WA
OUE Healthcare Ltd.
S$ 0.04
+2.5641%
F86
MYP Ltd.
S$ 0.06
-1.7857%

Hyphens Pharma International Limited (1J5) FAQ

What is the stock price today?

The current price is S$0.37.

On which exchange is it traded?

Hyphens Pharma International Limited is listed on SGX.

What is its stock symbol?

The ticker symbol is 1J5.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 108.11M.

Has Hyphens Pharma International Limited ever had a stock split?

No, there has never been a stock split.

Hyphens Pharma International Limited Profile

Pharmaceuticals Industry
Healthcare Sector
Mr. See Wah Lim CEO
SGX Exchange
- ISIN
Singapore Country
455 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Hyphens Pharma International Limited operates primarily in the healthcare sector, serving as a specialty pharmaceutical and consumer healthcare company. It has established a robust presence not only in its home base of Singapore but also in Vietnam, Malaysia, and other international markets. Structured around three main operational segments — Specialty Pharma Principals, Proprietary Brands, and Medical Hypermart and Digital — the company focuses on the marketing, sale, and distribution of a wide range of pharmaceutical products and medical supplies. Originally founded in 1998 under the name Hyphens Pharma International Pte Ltd, it underwent a name change to Hyphens Pharma International Limited in May 2018, marking its growth and expansion in the pharmaceutical and healthcare industries. The company's headquarters are located in Singapore.

Products and Services

  • Specialty Pharma Principals: This segment is dedicated to the marketing and distribution of specialty pharmaceutical products. It includes:
    • Stérimar nasal sprays: Targeted for allergy and otorhinolaryngology therapeutic areas.
    • Bausch+Lomb eye drops: Aimed at addressing ophthalmological needs.
    • Vivomixx: A supplement for gastroenterology.
    • Fenosup Lidose and Piascledine: Used in orthopedic, rheumatology, and other specialized fields.
  • Proprietary Brands: Focused on the development, marketing, and sale of dermatological and health supplement products. It encompasses:
    • Ceradan and TDF dermocosmetic products: Distributed via medical professionals to address skin care needs.
    • Ocean Health health supplements: Sold directly to consumers through retail channels for various health benefits.
    • CG 210 scalp care products: Offered through medical professionals to help with scalp health.
  • Medical Hypermart and Digital: This segment encompasses the wholesale of pharmaceuticals and medical supplies, aimed at healthcare professionals and institutions. Key offerings include:
    • Tele-sales and sales representatives: Facilitate the distribution of products.
    • Online B2B platform: A digital marketplace for business customers.
    • WellAway e-pharmacy: An online pharmacy offering a range of healthcare products and medications for consumers.

Contact Information

Address: 16 Tai Seng Street
Phone: 65 6338 8551